Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
Yan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Repub...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGM |
id |
doaj-eb5e8554a6ce4e598b15eb83d6f13907 |
---|---|
record_format |
Article |
spelling |
doaj-eb5e8554a6ce4e598b15eb83d6f139072021-09-16T19:51:46ZengDove Medical PressInternational Journal of General Medicine1178-70742021-09-01Volume 145835584368920Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric CancerHu YLi JLuo HSong WYang JYan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaTel +86 716 8513623Email yanhu_dr@outlook.comBackground: Gastric cancer (GC) is among the most prevalent cancers globally. As such, there is a need to explore the mechanism underlying its pathogenesis and identify potential biomarkers for its prognosis.Methods: ONCOMINE was used to screen differentially expressed genes between GC and normal gastric mucosa. GEPIA was used to analyze the expression and correlation of candidate genes in tumor node metastasis (TNM) stage. STRING was used to construct protein interaction network. Kaplan–Meier plotter was used to analyze survival. TIMER was used to evaluate the association between candidate genes and immune cell infiltration.Results: From the ONCOMINE database, we found COL1A1, COL1A2, COL6A3, and SULF1 genes were significantly upregulated in stomach adenocarcinomas. There was a considerable correlation between the expression of COL1A1 (p = 0.029), COL1A2 (p = 0.004), COL6A3 (p = 0.002), SULF1 (p = 0.001), and the TNM stage. COL1A1 was positively correlated with ERBB2 (R = − 0.037, p = 0.46), while the other three genes were negatively correlated with ERBB2 (p > 0.05). The Kaplan–Meier plotter showed that low transcriptional levels of COL1A1 (p = 0.0020), COL1A2 (p = 0.0015), COL6A3 (p = 0.0015), and SULF1 (p = 0.0016) in gastric cancer patients were remarkably related to longer overall survival. In addition, there was a close relationship between chemokine expression and infiltration of the six immune cell types: B cells, macrophages, CD4+ T cells, CD8+ T cells, dendritic cells, and neutrophils, implying that the genes acted as indicators of both prognosis and immune status.Conclusion: Our findings implicate COL1A1, COL1A2, COL6A3, and SULF1 as candidate biomarkers for the prognosis of gastric cancer.Keywords: gastric cancer, biomarker, prognosishttps://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGMgastric cancerbiomarkerprognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hu Y Li J Luo H Song W Yang J |
spellingShingle |
Hu Y Li J Luo H Song W Yang J Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer International Journal of General Medicine gastric cancer biomarker prognosis |
author_facet |
Hu Y Li J Luo H Song W Yang J |
author_sort |
Hu Y |
title |
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer |
title_short |
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer |
title_full |
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer |
title_fullStr |
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer |
title_full_unstemmed |
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer |
title_sort |
differential expression of col1a1, col1a2, col6a3, and sulf1 as prognostic biomarkers in gastric cancer |
publisher |
Dove Medical Press |
series |
International Journal of General Medicine |
issn |
1178-7074 |
publishDate |
2021-09-01 |
description |
Yan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaTel +86 716 8513623Email yanhu_dr@outlook.comBackground: Gastric cancer (GC) is among the most prevalent cancers globally. As such, there is a need to explore the mechanism underlying its pathogenesis and identify potential biomarkers for its prognosis.Methods: ONCOMINE was used to screen differentially expressed genes between GC and normal gastric mucosa. GEPIA was used to analyze the expression and correlation of candidate genes in tumor node metastasis (TNM) stage. STRING was used to construct protein interaction network. Kaplan–Meier plotter was used to analyze survival. TIMER was used to evaluate the association between candidate genes and immune cell infiltration.Results: From the ONCOMINE database, we found COL1A1, COL1A2, COL6A3, and SULF1 genes were significantly upregulated in stomach adenocarcinomas. There was a considerable correlation between the expression of COL1A1 (p = 0.029), COL1A2 (p = 0.004), COL6A3 (p = 0.002), SULF1 (p = 0.001), and the TNM stage. COL1A1 was positively correlated with ERBB2 (R = − 0.037, p = 0.46), while the other three genes were negatively correlated with ERBB2 (p > 0.05). The Kaplan–Meier plotter showed that low transcriptional levels of COL1A1 (p = 0.0020), COL1A2 (p = 0.0015), COL6A3 (p = 0.0015), and SULF1 (p = 0.0016) in gastric cancer patients were remarkably related to longer overall survival. In addition, there was a close relationship between chemokine expression and infiltration of the six immune cell types: B cells, macrophages, CD4+ T cells, CD8+ T cells, dendritic cells, and neutrophils, implying that the genes acted as indicators of both prognosis and immune status.Conclusion: Our findings implicate COL1A1, COL1A2, COL6A3, and SULF1 as candidate biomarkers for the prognosis of gastric cancer.Keywords: gastric cancer, biomarker, prognosis |
topic |
gastric cancer biomarker prognosis |
url |
https://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGM |
work_keys_str_mv |
AT huy differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer AT lij differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer AT luoh differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer AT songw differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer AT yangj differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer |
_version_ |
1717377943258267648 |